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Post-traumatic stress response, which occursimmediately after trauma, is a complex adap-tive phenomenon, involving the synchronized
interaction of multiple neuronal and endocrine pathways
geared at restoring homeostasis. Immune inflamma-
tory response has been recognized to be a key ele-
ment both in the pathogenesis of post-traumatic com-
plications and in tissue repair. It has been demonstrated
that there is bidirectional network between neuroendo-
crine and immune systems. Although this interaction
constitutes a pivotal feedback loop that optimizes im-
mune inflammatory responses after trauma, prolonged
or inappropriate neuroendocrine responses might also
predispose the host to excess inflammation or uncon-
trolled infection, finally leading to pathological and le-
thal effects, including development of traumatic com-
plications 1 and delayed wound healing 2.
Neuroendocrine regulation of immunity occurs
through systemic, regional and local routes. 3 The local
route, peripheral nervous system, regulates local in-
flammatory responses through the release of neuropep-
tides in local injury area. The sympathetic (or adrenergic)
nervous system (SNS) and the parasympathetic (or
cholinergic) nervous system modulate inflammation
through innervation of immune organs at a regional level.
Neuroendocrine responses control inflammation at a
systemic level by the hypothalamic-pituitary-adrenal
(HPA) axis through glucocorticoids released from the
adrenal cortex, by the hypothalamic–pituitary–gonadal
(HPG) axis through sex hormones released from the
ovaries and testes, and by the hypothalamic–pituitary–
thyroid hormone axis through thyroid hormones released
from the thyroid gland. Despite the multiple and intri-
cate interconnected pathways, the two pathways at the
core of the stress system wiring are the HPA axis and
the SNS. The core function of the HPA and SNS path-
ways is central to the host’s adaptation to acute chal-
lenges by ensuring energy substrate mobilization, car-
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Stress or neuroendocrine response usually occurs soon
after trauma, which is central to the maintenance of post-
traumatic homeostasis. Immune inflammatory response has
been recognized to be a key element both in the pathogene-
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nected neuroendocrine pathways, the hypothalamic-pitu-
itary-adrenal (HPA) axis and the sympathetic nervous sys-
tem have been considered to be the most important in trauma.
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role of neuroencrine system in trauma.
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diovascular and hemodynamic compensation, increas-
ing awareness, and subsequently by contributing to host
immune function and tissue repair. Although the short-
term and appropriate activation of these stress re-
sponses is vital to the host’s adaptation, prolonged
duration and increased magnitude of their activity lead
to deleterious effects on immune function in trauma,4
causing immune dissonance. Thus, the overall appro-
priate and controlled activation and termination of the
neuroendocrine responses that mediate the necessary
physiological functions involved in maintaining and re-
storing homeostasis in trauma are of critical importance.
This review will describe the effects of some important
neuroendocrine responses on immune system. Present
evidences indicate that the neuroendocrine and immune
systems form a cohesive and integrated early host re-
sponse to trauma, and identify areas for future research
to fully elucidate the regulatory role of neuroendocrine
system in trauma.
Regulatory role of hypothalamic-pituitary-adrenal
(HPA) axis on immune system
HPA consists of a set of brain regions (the
hypothalamus) and endocrine organs (the pituitary and
cortex of the adrenal glands). In response to stress,
corticotropin-releasing hormone (CRH) is first secreted
from cells of the paraventricular nucleus of the hypo-
thalamus into the hypophyseal blood supply around the
pituitary gland. CRH then stimulates the release of
adrenocorticotropic hormone from the anterior pituitary
into the blood, which in turn stimulates the synthesis
and release of endogenous glucocorticoids from the
adrenal cortex. The glucocorticoids are the effector
hormones for HPA. In addition to their role in maintain-
ing metabolic homeostasis, glucocorticoids are essen-
tial for the modulation of immune functions in both acute
and chronic stresses.5
In general, glucocorticoids have been considered
as an immune suppressor. Fluctuations in the levels of
circulating glucocorticoids, such as circadian variations
or fluctuations that occur after stress, have been shown
to be correlated with decreases in IL-1β and tumor-
necrosis factor (TNF) production by leukocytes.6,7
Furthermore, glucocorticoids have been shown to sup-
press maturation, differentiation and proliferation of all
immune cells, including dendritic cells (DCs) and
macrophages. Glucocorticoids inhibit DC differentiation
depending on the stage of maturation.8 Glucocorticoids
also reduce the capacity of  DCs to promote
allostimulatory responses and efficient activation of naive
T cells in vitro, possibly owing to downregulation of
expression of MHC class II and co-stimulatory
molecules.9 In vivo, dexamethasone (a synthetic
glucocorticoid) impairs the ability of rat thymic DCs to
produce IL-1βand TNF, but not IL-10.10 Dexametha-
sone also inhibits IL-12p40 production by LPS-stimu-
lated human monocytes by downregulation of activa-
tion of JUN N-terminal kinase (JNK), mitogen-activated
protein kinase (MAPK), activator protein 1 (AP1) and
nuclear factor-κB  (NF-κB ).11 In addition, glucocorti-
coids could cause a shift in adaptive immune responses
from a T helper 1 (TH1) type to a TH2 type, which is
largely through inhibiting the production of the TH1-cell-
inducing cytokine interleukin-12 (IL-12) by DCs and
macrophages. 12 With respect to effects on immune-
cell trafficking, glucocorticoids have been shown to in-
hibit the expression of many cell-adhesion molecules
involved in cell trafficking, including intracellular adhe-
sion molecule 1 (ICAM1), endothelial-leukocyte adhe-
sion molecule 1 (ELAM1), also known as E-selectin
and vascular adhesion molecule 1 (VCAM1). 13,14 Glu-
cocorticoids also inhibit the production and secretion
of chemokines, such as CC-chemokine ligand 2 (CCL2,
or MCP1) and CXC-chemokine ligand 8 (CXCL8, or IL-8)
by eosinophils, as well as chemoattractant IL-5 by mast
cells and T cells. 15 In addition, dexamethasone can
downregulate T-cell expression of CCL8 (also known
as MCP2) and CCL7 (also known as MCP3), which are
chemotactic for many cell types including monocytes,
DCs, and natural killer cells. 16
In addition to their immunosuppression, glucocor-
ticoids, at some circumstances, have been shown to
enhance immune function. Results from our lab recent-
ly have indicated that corticosterone in vitro could en-
hance phagocytosis and chemotaxis of mouse peritoneal
macrophages in a lower concentration (≤50 ng/ml) and
for short duration of stimulation. At this case, cortisos-
terone also enhances the capacity of macrophages to
produce TNF-α.17 Dhabhar18 further indicated that glu-
cocorticoids could increase delayed-type hypersensi-
tivity in physiological concentrations. Some other re-
ports have indicated that the physiological role of en-
dogenous glucocorticoids might be distinct from the
effects of therapeutic concentrations of synthetic corti-
sol analogues. For example, dexamethasone suppres-
sion of IL-6 production has been reported, but the en-
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dogenous glucocorticoid, cortisol, is 25 times less ef-
fective than synthetic cortisol analogues in suppress-
ing the cytokine. Suppression of IL-6 by cortisol only
occurr at concentrations that are never attained in vivo.
19 Furthermore, inhibition of NF-κB requires high con-
centrations of dexamethasone (1×10-6–1×10-7 mol/L dex-
amethasone in vitro or 1 mg/kg in vivo) comparable to
those obtained by high-dose daily or pulse glucocorti-
coid (GC) therapy. In addition, interruptions of the HPA
axis, through surgical interventions (adrenalectomy or
hypophysectomy) or through pharmacological interven-
tion with glucocorticoid antagonists (such as RU486),
renders otherwise relatively inflammation-resistant ani-
mals highly susceptible to both endogenous and exog-
enous bacterial infection.20-22 Conversely, reconstitution
of the HPA axis treated with exogenous glucocorticoids
or by hypothalamic transplantation reverses this effect
and prevents mortality in these animal models. 20-23 The
above data indicate that glucocorticoids might have dual
effects on immune system, which largely depends upon
the magnitude and duration of stress.
Regulation of sympathetic nervous system on im-
mune systems
The SNS regulates immune system through the in-
nervation of immune organs and the release of norad-
renaline at a regional level, and through the release of
adrenaline from the medulla of the adrenal glands at a
systemic level. In lymphoid tissues, both lymphocytes
and macrophages are adjacent to neuronal fibers, ex-
posing them to local release of neuropeptides forming
synaptic-like neuroimmune interactions, allowing modu-
lation of localized inflammatory responses through di-
rect neural release and humoral neuroendocrine
mediators. The local release of neuroendocrine media-
tors coupled with specific receptor expression in im-
mune cells establishes a functional neuroimmune con-
nection capable of modulating various immune
responses, including cytokine production, neutrophil
chemotaxis, phagocytosis, and reactive oxygen spe-
cies production and release.4
There are more and more evidences indicating that
SNS exerts an important modulation on immune
system, showing immunosuppressive in most studies.
In vitro, noradrenaline mediates its immunosuppressive
effects on DCs and monocytes by inhibiting LPS-in-
duced production of TNF, 24 IL-12, 25 and macrophage
inhibitory protein 1α26 and enhance LPS-stimulated
release of IL-10. 27 Pharmacological blockade of adrener-
gic receptors potentiates IL-6 secretion and inhibits IL-10
secretion in vivo. The peritoneal macrophages obtained from
sympathectomized mice can increase TNF-αproduction
in response to LPS stimulation. Noradrenaline also in-
creases the secretion of the chemotactic chemokine
CXCL8 by fibroblasts isolated from patients with rheu-
matoid arthritis and promotes the migration of NK cells,
monocytes and macrophages, but inhibits DC migra-
tion in vitro. 28 Noradrenaline inhibits the in vitro DC
chemotactic response to the chemokines CCL19 and
CCL21 (which are important for DC migration from the
site of antigens to regional lymph nodes), through
upregulation of anti-inflammatory IL-10 production. In
vivo studies have shown that catecholamines affect
dendritic cell function, enhancing myelopoiesis and
suppressing lymphopoiesis through specific adrener-
gic receptor mechanisms.29 Results from interruptions
of SNS by chemical sympathectomy or  by surgically
cutting sympathetic nerve innervation of lymphoid or-
gans further demonstrate the role of SNS in regulating
immunity at a regional level. The removal of tissue nore-
pinephrine stores could result in an exacerbated rise in
lung TNF expression and NF-κB activation after hemo-
rrhagic shock and fluid resuscitation. 30
However, results from our lab recently indicated that
short exposure of mouse peritoneal macrophages to lower
concentration of noradrenaline or adrenaline could lead
to increases in cytokine production, chemotaxis, adhe-
sion and phagocytosis. In addition, such a treatment
could also enhance LPS-induced cytokine production.
Some other studies also show that catecholamines and
SNS activation could increase immune and pro-inflam-
matory responses at some circumstances. 31,32 These
conflictive conclusions have been explained partially by
different effects mediated by the specific receptor
subtypes. Catecholamines act on their target cells by
binding to cell surface adrenergic receptors. Reports
indicate thatα-andβ-adrenergic receptors are ex-
pressed in immune cells, withβ-adrenergic receptors
having a wider expression in these cells. Catechola-
mines have been considered to suppress pro-inflam-
matory cytokine production throughβ-adrenergic
receptors, but enhance pro-inflammatory cytokine pro-
duction throughα-adrenergic receptors. 33 In addition,
regulation of catecholamines on immune cells also
depends on the type of cells and the stimulation condi-
tions of the hormones.
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Parasympathetic control of immunity
The parasympathetic nervous system modulates
immune responses at a regional level through both the
efferent and afferent fibres of the vagus nerve. The affer-
ent fibres of the vagus nerve can signal the presence of
peripheral inflammation to the brain. It has been demon-
strated that pro-inflammatory cytokines, such as IL-1
released by activated innate immune cells in local
tissues, bind to cytokine receptors on the surfaces of
paraganglia cells, activate afferent fibres of the vagus
nerve and induce rapid activation of parasympathetic
brainstem regions, which then leads to the release of
acetylcholine from efferent vagus nerve fibres and re-
sultant negative-feedback control of inflammation.34 The
primary effector neurotransmitter of the parasympathetic
nervous system is acetylcholine, which binds to two
general receptor subtypes, nicotinic and muscarinic
cholinergic receptors. Both receptors are found in im-
mune cells, but nicotinic receptors specifically medi-
ate cholinergic anti -inf lammatory ef fects in
macrophages. 35 Activation of this receptor on macroph-
ages inhibits NF-κB  signaling, thereby repressing pro-
inflammatory cytokine production.35 A recent report also
indicates that nicotine, a cholinergic agonist, inhibits
macrophage cytokine production by recruiting JAK2
(Janus kinase 2) to theα7 subunit. This initiates the
anti-inflammatory STAT3 (signal transducer and activa-
tor of transcription 3) and SOCS3 (suppressor of cytokine
signaling 3) signaling cascades. The cholinergic neu-
ronal inflammatory reflex pathway also prevents in-
creased serum concentrations of TNF during toxic
shock, through the release of acetylcholine from the
vagus nerve, indicating that this pathway plays an im-
portant role in preventing excessive inflammatory
responses. Accordingly, vagotomy exacerbates the TNF
response to inflammatory stimuli and sensitizes ani-
mals to the lethal effects of endotoxin, whereas cholin-
ergic agonists and vagus-nerve stimulation prevent these
effects.34 Acetylcholine also inhibits endotoxin-induced
release of pro-inflammatory cytokines (IL-1, IL-6 and
TNF) but not anti-inflammatory cytokines (IL-10) from
macrophages.35 Additional support for a role for the para-
sympathetic nervous system in dampening inflamma-
tory responses is provided by acetylcholine-mediated
inhibition of high mobility group box 1 (HMGB1), a pro-
tein released by activated macrophages during severe
sepsis. Therefore, as for glucocorticoid and SNS regu-
lation of innate immunity, the parasympathetic nervous
system is activated by cytokines released during acti-
vation of the innate immune system, and in turn pro-
vides a negative feedback control of innate immune re-
sponses to restore homeostasis. There are some con-
troversies in the literature regarding the cellular source
of acetylcholine that regulates inflammation. It has been
suggested that the source of acetylcholine acting on
macrophages is more likely to be immune-cell derived
than released from nerve endings.36
Regulation of immune system on neuroendocrine
responses
It has been demonstrated that there is a bidirec-
tional communication between nervous and immune
systems. There is considerable evidence that the pe-
ripheral immune system can signal the brain to elicit
neuroendocrine response through immune mediators
and cytokines. The peripheral immune molecules influ-
ence neuroendocrine responses through various
mechanisms, including cytokine’s direct entry into the
brain as well as stimulation of afferent neurons of the
vagus nerve. 37 Regarding to the passage of cytokines
across the blood brain barrier, there are at least two
pathways. One of them is through fenestrated capillar-
ies in different regions of the CNS. These sites are rela-
tively devoid of a blood-brain barrier such as the struc-
tures lining the anteroventral border of the third ven-
tricle and the posterior lobe of the pituitary. Their capil-
laries do not form tight junctions and are thus far more
readily penetrable via the paracellular route.38 Another
possibility is increased permeability of the blood-brain
barrier after trauma, which enhances the access of
peripheral immune cells or their products to the CNS. 39
The mechanisms involved in the interaction between
peripheral cytokines and vagal fibers are still under
investigation. The localized perivagal cytokine produc-
tion may contribute to this signaling mechanism.40 This
afferent signaling pathway to the CNS in response to
peripheral inflammatory challenges functions as a feed-
back mechanism. This bidirectional neuroimmune in-
teraction creates a circuit of responses that can be
considered as an inflammatory reflex. The integrity of
such circuit is critical in host protection and adaptation
to systemic challenges such as traumatic injury and
infection.
Conclusion
To control inflammation during a period after injury
is essential for tissue repair and maintenance of im-
mune competence. The initiation and termination of the
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inflammatory response is under neuroendocrine con-
trol through direct neurotransmitter release at the tar-
get organ, as well as indirect action through humoral
factors, including catecholamines, neuropeptides, and
glucocorticoids. Although the early post-traumatic in-
flammatory response is directed to repair tissues and
establish immune competence, an increased magni-
tude and duration of this response is associated with
delayed restoration of homeostasis and increases tis-
sue injury leading to multiple organ failure. The neu-
roendocrine responses have been demonstrated to ex-
ert direct effects on cells of the immune system, affect-
ing cytokine expression, lymphocyte function, and cy-
totoxic activity. In turn, the inflammatory mediators re-
leased communicate with the CNS through stimulation
of sensory and vagal afferents or by crossing the blood-
brain barrier through active transport mechanisms or
by taking advantage of areas with fenestrated capillaries.
This neuroendocrine-immune feedback loop is pivotal
to maintenance of immune homeostasis in trauma. Neu-
roendocrine response might have varying effects on
immune system, enhancing or dampening, which might
be dependent on the magnitude of neuroendocrine
responses, presence of immune challenge, type of im-
mune cells, and so on.
For many years, the concept that the central and pe-
ripheral nervous systems regulate immunity is considered
to be highly controversial. However, as described in this
review, a wealth of data has now been accumulated, indi-
cating that the molecular machinery required to respond
to neurotransmitters, neuropeptides and neurohormones
are indeed present in immune cells. In addition, in some
cases, immune cells produce and secrete neural
mediators, supporting the importance of such mecha-
nisms of immune regulation. However, the precise cel-
lular source and maturation phase at which immune
cells either produce such molecules or respond to them
still requires clarification. In addition, the signalling
mechanisms and physiological circumstances under
which such regulation occurs largely remain
unaddressed. And with most studies so far focusing on
the effects of glucocorticoids on innate immune
responses, evidence for a role of other neuropeptides
and neurotransmitters in innate recognition systems,
such as TLRs on immune cells, is scarce. Research
that focuses on these issues should provide further
important insights into the molecular mechanisms and
physiological role of the links between the immune sys-
tem and the CNS that occur at systemic, regional and
local levels, and will provide further evidence that these
interactions have important physiological roles in health
and disease.
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